RDHL Stock Analysis: Buy, Sell, or Hold?

RDHL - Redhill Biopharma Ltd.

Pharmaceutical Preparations
$1.22
-0.05 (-3.94%) ▼
WAIT
LOW Confidence
Protect Your RDHL Gains
Last Updated: January 30, 2026
Earnings: Mar 12, 2026

Get Alerted When RDHL Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
⏸️ WAIT FOR STABILIZATION: RDHL is down 10.3% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.

In-depth Analysis How we analyze

Valuation Analysis: RDHL is currently trading at $1.22, which is considered fair relative to its 30-day fair value range of $1.14 to $1.35.

Technical Outlook: Technically, RDHL is in a downtrend. The price is currently testing key support at $1.20. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.9% recently.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $19000.00 (+1495963.0%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Fair Price Range $1.14 - $1.35
Company Quality Score 53/100 (HOLD)
Volume Confirmation MODERATE
Confidence Score 64.2%

Protect Your Profits

Holding RDHL? Use our AI-powered strategies to protect your downside while keeping your long-term position.

View Profit Protection Plan

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BEARISH: Downward momentum (-3.9%)
  • BULLISH: Trading 1495963.0% below Wall St target ($19000.00)
  • WARNING: Recommendation downgraded due to -10.3% 5-day decline - wait for stabilization

Fair Price Analysis

30-Day Fair Range $1.14 - $1.35
Current vs Fair Value FAIR

Support & Resistance Levels

Support Level $1.20
Resistance Level $1.39
Current Trend Downtrend

Fundamental Context

Forward P/E (Next Year Est.) 1428.57
Wall Street Target $19000.00 (+1495963.0%)
Revenue Growth (YoY) 58.6%
Profit Margin -97.5%
Last updated: January 30, 2026 7:34 PM ET
Data refreshes hourly during market hours. Next update: 8:34 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Top Rated Drug Manufacturers - Specialty & Generic Stocks

Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
NBIX
Neurocrine Biosciences I…
STRONG BUY
25 analysts
$179 62 BUY
ZTS
Zoetis Inc
STRONG BUY
19 analysts
$158 56 HOLD
LNTH
Lantheus Holdings Inc
STRONG BUY
13 analysts
$84 57 HOLD
BCRX
BioCryst Pharmaceuticals…
STRONG BUY
12 analysts
$21 55 HOLD
HCM
HUTCHMED DRC
STRONG BUY
14 analysts
$21 57 HOLD

Advanced RDHL Option Strategies

Professional options setups generated by AI based on today's RDHL price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for RDHL

RDHL Technical Chart RDHL Price Prediction RDHL Earnings Date RDHL Investment Advisor RDHL Fair Price Analyzer RDHL Options Advisor RDHL Options Chain RDHL Options Analysis RDHL Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals